drugset
drugset / Trial / NCT00515255

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

NCT00515255 ↗

Phase 2 Terminated 6 enrolled Neuropharm
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Timeline

Start
2007-07
Primary completion
2008-04
Completion
2008-04

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment Goal of 20 Not Met”

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule — —

Indications

obsessive-compulsive disorder